🇺🇸 Salmeterol/ fluticasone propionate in United States

57 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 57

Most-reported reactions

1. Drug Interaction — 10 reports (17.54%)
2. Dyspnoea — 8 reports (14.04%)
3. Pyrexia — 7 reports (12.28%)
4. Pneumonia — 6 reports (10.53%)
5. Atrial Fibrillation — 5 reports (8.77%)
6. Diarrhoea — 5 reports (8.77%)
7. Adrenal Suppression — 4 reports (7.02%)
8. Asthma — 4 reports (7.02%)
9. Hypogammaglobulinaemia — 4 reports (7.02%)
10. Malaise — 4 reports (7.02%)

Source database →

Frequently asked questions

Is Salmeterol/ fluticasone propionate approved in United States?

Salmeterol/ fluticasone propionate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Salmeterol/ fluticasone propionate in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.